AN2 Therapeutics Inc. (ANTX)
NASDAQ: ANTX
· Real-Time Price · USD
1.10
0.05 (4.27%)
At close: Aug 15, 2025, 3:59 PM
1.11
0.78%
After-hours: Aug 15, 2025, 07:15 PM EDT
AN2 Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 80K | 80K | 80K | 80K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | 40K | 40K | 61K | 80K | 60K | 80K | 78K | 59K | 39K | 19K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | 40K | 40K | 19K | n/a | -60K | -80K | -78K | -59K | -39K | -19K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -41.37M | -50.03M | -56.79M | -67M | -71.17M | -71.89M | -69.64M | -63.3M | -56.89M | -50.62M | -42.21M | -37.33M | -32.49M | -27.15M | -21.57M | -13.98M | -7.05M | -2.05M |
Interest Income | 1.64M | 888K | 1.68M | 1.68M | 1.68M | 1.68M | n/a | 630K | 1.1M | 1.32M | 1.35M | 748K | 307K | 94K | 69K | 42K | 17K | 2K |
Pretax Income | -37.38M | -45.35M | -51.32M | -60.7M | -64.66M | -66.03M | -64.73M | -59.68M | -54.31M | -48.62M | -40.96M | -36.66M | -32.26M | -27.15M | -21.54M | -14M | -7.05M | -2.05M |
Net Income | -37.38M | -45.35M | -51.32M | -60.7M | -64.66M | -66.03M | -64.02M | -59.91M | -54.11M | -48.42M | -41.47M | -36.23M | -32.26M | -27.15M | -21.54M | -14M | -7.05M | -2.05M |
Selling & General & Admin | 14.56M | 14.27M | 14.07M | 14.75M | 15.02M | 14.35M | 14.76M | 14.59M | 14.18M | 14.76M | 12.75M | 10.81M | 9.05M | 6.32M | 4.67M | 2.89M | 1.3M | 401K |
Research & Development | 24.57M | 33.52M | 40.49M | 50.01M | 56.15M | 57.54M | 54.87M | 48.7M | 42.7M | 35.86M | 29.51M | 26.57M | 23.49M | 20.89M | 16.91M | 11.09M | 5.75M | 1.65M |
Other Expenses | 2.23M | 2.23M | 2.23M | 2.24M | n/a | n/a | n/a | 4K | -31K | -46K | -45K | -27K | -28K | -37K | -38K | -60K | -24K | n/a |
Operating Expenses | 41.37M | 50.03M | 56.79M | 67M | 71.17M | 71.89M | 69.64M | 63.3M | 56.89M | 50.62M | 42.26M | 37.38M | 32.54M | 27.21M | 21.57M | 13.98M | 7.05M | 2.05M |
Interest Expense | n/a | n/a | n/a | 716K | 716K | 716K | 716K | n/a | n/a | n/a | n/a | n/a | n/a | 15K | 17K | 17K | 17K | 2K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 41.37M | 50.03M | 56.79M | 67M | 71.17M | 71.89M | 69.64M | 63.3M | 56.89M | 50.62M | 42.26M | 37.38M | 32.54M | 27.21M | 21.57M | 13.98M | 7.05M | 2.05M |
Income Tax Expense | n/a | n/a | n/a | -18.82K | -36.99K | -57.99K | -774K | 189.82K | -223K | -202K | 459K | -486K | -55K | -55K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 30.17M | 30.05M | 29.88M | 29.84M | 29.82M | 29.76M | 29.73M | 25.64M | 19.5M | 19.39M | 19.4M | 19.35M | 19.26M | 19M | 18.14M | 14.05M | 14.05M | 14.05M |
Shares Outstanding (Diluted) | 30.17M | 30.05M | 29.88M | 29.84M | 29.82M | 29.76M | 29.73M | 25.64M | 19.5M | 19.39M | 19.4M | 19.35M | 19.26M | 19M | 18.14M | 14.05M | 14.05M | 14.05M |
EPS (Basic) | -1.24 | -1.51 | -1.72 | -2.04 | -2.26 | -2.59 | -2.78 | -2.87 | -2.78 | -2.49 | -2.14 | -1.9 | -1.97 | -1.94 | -1.74 | -1.32 | -0.69 | -0.2 |
EPS (Diluted) | -1.24 | -1.51 | -1.72 | -2.04 | -2.26 | -2.59 | -2.78 | -2.87 | -2.78 | -2.49 | -2.14 | -1.9 | -1.97 | -1.94 | -1.74 | -1.32 | -0.69 | -0.2 |
EBITDA | -38.05M | -46.71M | -50.24M | -59.61M | -66.02M | -66.74M | -67.72M | -63.3M | -56.89M | -50.62M | -42.26M | -37.38M | -32.54M | -27.21M | -21.57M | -13.98M | -7.05M | -2.05M |
EBIT | -37.29M | -46.71M | -51.79M | -61.17M | -67.58M | -68.3M | -67.72M | -63.3M | -56.89M | -50.41M | -42.02M | -37.14M | -32.3M | -27.18M | -21.57M | -13.98M | -7.05M | -2.05M |
Depreciation & Amortization | n/a | 25.41M | 43.7M | 43.7M | 61.88M | 36.5M | 18.22M | 18.24M | 80K | 78K | 7.74M | 15.32M | 22.23M | 22.21M | 14.53M | 6.93M | n/a | n/a |